Join us June 25-27, 2019 for Antibody Engineering & Therapeutics Digital Week, a global 4-day series of live educational webcasts and downloadable resources providing the latest insights for accelerating next generation antibodies to commercial success. To sponsor future digital events, contact partners@knect365lifesciences.com or request details.
Accelerating target-to-lead antibody candidate selection using the Berkeley Lights Beacon Platform
June 26, 2019
9am EDT / 2pm BST / 3pm CEST
The development of biologics to novel therapeutic targets is hampered by current antibody discovery technologies that are laborious, time-consuming, and generate limited diversity.
In this webinar, they will demonstrate how Berkeley Lights’ BeaconTM platform’s automated plasma cell antibody discovery workflow mines the vast immune repertoire to identify B cells producing rare, functional antibodies to difficult therapeutic targets in under 24 hours. Unlike other single-cell technologies, the Beacon platform enables users to perform multiple functional assays to enable selection of lead candidates against difficult therapeutic targets. The Beacon platform links phenotype-to-genotype at the single-cell level, thus simplifying downstream sequencing, cloning, and bioinformatics analysis.
Speaker:
Anupam Singhal, PhD
Senior Manager, Technology Development
Berkeley Lights, Inc.